Joseph Ronald Catapano
Known title: Chief Accounting OfficerCIK: 0001714468
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Pitney Bowes (PBI) posts strong cash flow, launches SendPro CX. The company disclosed robust cash flow, which analysts say improves its valuation appeal. It also introduced the SendPro CX series, expanding its product portfolio. These developments are noted alongside commentary that the stock offers a high dividend yield and may fit a steady‑growth profile. The news adds to recent coverage highlighting its attractive yield and potential upside.
Transaction History
| TDOC | ▼ Sell | Open Market | 655 | $4K | 10/2/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,083 | — | 10/1/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 274 | $2K | 9/2/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 833 | — | 9/1/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 39 | — | 9/1/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 653 | $6K | 7/2/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,083 | — | 7/1/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 284 | $2K | 6/2/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 39 | — | 6/1/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 833 | — | 6/1/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 675 | $3K | 4/2/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,083 | — | 4/1/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 1,333 | $7K | 3/2/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 3,333 | — | 2/27/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 155 | — | 2/27/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 758 | $5K | 1/5/2026 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 2,083 | — | 1/2/2026 | View on chart |
| TDOC | ▼ Sell | Open Market | 2,972 | $23K | 10/2/2025 | View on chart |
| TDOC | ▲ Buy | Option Exercise | 8,333 | — | 10/1/2025 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 1,212 | $8K | 9/6/2024 | View on chart |
| PBI | ▲ Buy | Option Exercise | 11,881 | $0 | 9/6/2024 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 3,783 | $25K | 9/6/2024 | View on chart |
| PBI | ▲ Buy | Option Exercise | 3,805 | $0 | 9/6/2024 | View on chart |
| PBI | ▲ Buy | Option Exercise | 5,919 | $0 | 3/12/2024 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 1,885 | $8K | 3/12/2024 | View on chart |
| PBI | ▲ Buy | Option Exercise | 11,880 | $0 | 2/27/2024 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 3,783 | $0 | 2/27/2024 | View on chart |
| PBI | ▲ Buy | Option Exercise | 1,903 | $0 | 2/27/2024 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 606 | $0 | 2/27/2024 | View on chart |
| PBI | ▲ Buy | Option Exercise | 5,918 | $0 | 3/14/2023 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 1,855 | $0 | 3/14/2023 | View on chart |
| PBI | ▲ Buy | Option Exercise | 11,881 | $0 | 2/28/2023 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 3,724 | $0 | 2/28/2023 | View on chart |
| PBI | ▲ Buy | Option Exercise | 8,559 | $0 | 2/14/2023 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 3,214 | $0 | 2/14/2023 | View on chart |
| PBI | ▲ Buy | Option Exercise | 5,919 | $0 | 3/8/2022 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 1,856 | $0 | 3/8/2022 | View on chart |
| PBI | ▲ Buy | Option Exercise | 13,722 | $0 | 2/8/2022 | View on chart |
| PBI | ▼ Sell | Tax Withholding | 5,098 | $0 | 2/8/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Teladoc Launches AI-Powered Remote Monitoring Tools
Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.
Teladoc Launches AI-Powered Remote Monitoring Tools. Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.